MMM heads into its July 17 Q2 earnings release with short sellers already offside — the retreat that began last week has continued, leaving the stock with one of the least crowded bear setups it has seen in months.
The short covering story is now largely told. Short interest fell another 11.6% on the week to 1.92% of the free float — consolidating the sharp drop from July 10, when bears covered aggressively ahead of results. The one-month arc remains instructive: shorts built steadily through June, rising roughly 19% before the reversal, suggesting positioning was tactical rather than structural. Borrow conditions confirm the lack of conviction on the bear side. Cost to borrow has eased further to 0.36%, its lowest reading of the past 30 days, and availability is essentially unlimited — over 500 million shares available to lend with no meaningful demand. The ORTEX short score has moved in lockstep, sliding from 32.7 to 31.5 over the past week, a gentle but consistent drift lower that reflects the same covered-and-gone dynamic.
Options traders are more relaxed than usual heading into the print. The put/call ratio has edged up marginally to 0.78 from the lows seen mid-week, but it remains well below its 20-day average of 0.86 — closer to the call-leaning end of recent history than the hedged end. The 52-week range runs from 0.40 to 1.66, so the current reading is neither extreme. Taken together, the positioning picture is notably unburdened: shorts have stepped aside, borrow is trivially cheap, and options traders are not paying up for downside protection.
The Street is divided on what the Q2 print will reveal. Bernstein initiated coverage in June with an Underperform rating and a $131 target — well below the current $156.58 price — flagging PFAS litigation tail risk and headwinds in China's industrial cycle. That sits against a more constructive camp: Wells Fargo (Overweight, $165) and Barclays (Overweight, $185) both maintained positive ratings after the Q1 report in April, even as they trimmed targets. RBC Capital holds Underperform at $133, echoing the bear case around the consumer segment's 2.2% revenue shortfall and slowing China industrial production. The mean price target of $175.56 implies meaningful upside from current levels, though the wide dispersion — from $131 to $185 among recent movers — reflects genuine disagreement rather than consensus comfort. On valuation, the stock trades at a P/E of 17.7x and EV/EBITDA of 11.8x, both roughly stable over the past month. The factor score picture adds nuance: the dividend score ranks in the 75th percentile and forward EPS momentum in the 66th, but EPS surprise history sits at just the 29th percentile — a reminder that 3M has a habit of disappointing relative to elevated expectations.
Earnings history offers two clean data points. The Q1 April print delivered a 3.7% one-day decline that persisted through the week. The May restatement event moved the other direction, up 2.6% on the day and 4.2% over five days. Neither print was large in absolute terms, suggesting the market treats 3M as a show-me story rather than a high-volatility event.
BlackRock and JP Morgan Asset Management are the two largest holders, with 8.2% and 7.6% respectively, both having added shares in the most recent reporting period. That steady institutional accumulation provides a passive floor, but active money will be watching whether 3M's Q2 margin trajectory — the 24.4% adjusted operating margin from Q3 2025 set the benchmark — holds or retreats under tariff and China demand pressure. Thursday's print is therefore less about whether 3M is growing and more about whether it is managing the gap between its own guidance and what the bears in the Bernstein-RBC camp believe the litigation and macro headwinds actually cost.
See the live data behind this article on ORTEX.
Open MMM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
